Journal profile · IMMUNOLOGY
American Journal of Clinical and Experimental Immunology
ISSN 2164-7712
American Journal of Clinical and Experimental Immunology: CAS Zone 4 · Medicine (2025 upgraded edition); subscription journal; median 120 days to acceptance (60 articles, last 24 months); 29 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
American Journal of Clinical and Experimental Immunology is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Breast Cancer Treatment Studies, together about 24.8% of its articles. Its main subfields are Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): IMMUNOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine11.3%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology7.2%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology6.2%
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology6.2%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.2%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.1%
- Asthma and respiratory diseasesMedicine4.1%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 7OpenAlex ·
- i10-index
- 4OpenAlex ·
- 2-year mean citedness
- 1.8OpenAlex ·
- Self-citation rate
- 15.8%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 28LetPub ·
Articles by year OpenAlex count · 82 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 24 | 76 |
| 2025 | 29 | 29 | 63 |
| 2024 | 29 | 29 | 9 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
120 daysMedian, submission to acceptance · P25–P75 57 days – 218 days
- Acceptance to online
- median 20 days (60 articles)
- Submission to online
- median 154 days
- Sample
- 60 articles with submission and acceptance dates (62 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- ISSN
- 2164-7712
FAQ
Frequently asked questions about American Journal of Clinical and Experimental Immunology
What CAS zone is American Journal of Clinical and Experimental Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, American Journal of Clinical and Experimental Immunology is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at American Journal of Clinical and Experimental Immunology?
Based on the dates recorded on 60 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 120 days (interquartile range 57–218 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index American Journal of Clinical and Experimental Immunology?
According to LetPub and DOAJ records, American Journal of Clinical and Experimental Immunology is indexed in ESCI.
Is American Journal of Clinical and Experimental Immunology open access, and what is the APC?
American Journal of Clinical and Experimental Immunology is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .